Trials / Completed
CompletedNCT06708806
Cell Ongrowth and Biocompatibility Study of Two Different (Hydrophobic Acrylic) Intraocular Lenses: IOL XY1 vs. IOL XY1A
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cataract surgery | bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (XY1) vs. an toric IOL (XY1A) |
Timeline
- Start date
- 2021-04-07
- Primary completion
- 2022-11-11
- Completion
- 2022-11-11
- First posted
- 2024-11-27
- Last updated
- 2024-11-27
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT06708806. Inclusion in this directory is not an endorsement.